Exploring Your Options: Could a Clinical Trial be Right for You?

Welcome to The Nerve, a podcast brought to you by the Facial Pain Association, dedicated to exploring all aspects of neuropathic facial pain. In this episode, host Brandi Underwood introduces a panel of experts from Noema Pharma who discuss the latest advancements in treating trigeminal neuralgia through the Libra study. Learn about the innovative trial design, patient involvement, and the investigational medication, NOE-101. The discussion delves into patient experiences and the collaborative efforts necessary to bring new hope and effective treatments to those suffering from facial pain.

This episode also guides listeners on how to participate in the trial and emphasizes the importance of patient-centered research. For more information and resources, visit FacePain.org.

For a deeper dive into the study, you can watch the full webinar, which includes a Q&A session with audience questions answered by the experts at https://youtu.be/kkpBrLtvzA8?

 

Disclaimer

The Facial Pain Association (FPA) is enthusiastic about medical research and encourages those with neuropathic facial pain, including trigeminal neuralgia, and related healthcare conditions to consider participation. It is important to note, however, that the FPA is not offering, nor is it qualified to offer, a scientific or medical endorsement of any Institutional Review Board (IRB) approved patient study.

An IRB is a committee established to review and approve research involving human subjects. The purpose of the IRB is to ensure that all human subject research is conducted in accordance with all federal, institutional, and ethical guidelines. All studies and trials listed have IRB or Ethics Committee approval where relevant. The study's safety and scientific validity is the sole responsibility of the study sponsors and investigators. Patients should use the contact information provided to contact the research organization for more information.

Choosing to participate in a study is an important personal decision. Before you participate in a study, discuss all options with your healthcare provider. Although study sponsors may donate to the FPA, or support the FPA through advertising or corporate sponsorship, such support does not influence or guide our decision about the studies we identify.

Noema Pharma is a sponsor of the Facial Pain Association.